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Abstract
Rheumatoid arthritis (RA) is a chronic, complex autoimmune inflammatory disorder with poorly
known etiology. Approximately 1% of the adult population is afflicted with RA. Linkage analysis of
RA can be complicated by the presence of phenotypic and genetic heterogeneity. It is shown that
the ordered-subset analysis (OSA) technique reduces heterogeneity, increases statistical power for
detecting linkage and helps to define the most informative data set for follow-up analysis. We
applied OSA to the family data from the North American Rheumatoid Arthritis Consortium study
as part of the Genetic Analysis Workshop 15 (GAW15). We have incorporated two continuous
covariates, 'age of onset' and 'anti-CCP level' (anti-cyclic citrinullated peptide), into our genome-
wide ordered-subset linkage analysis using 809 Illumina SNP markers in 5713 individuals from 606
Caucasian RA families. A statistically significant increase in nonparametric linkage (NPL) scores was
observed with covariate 'age of onset' in chromosomes 4 (p = 0.000003) and 9 (p = 0.002). With
the covariate 'anti-CCP level', statistically significant increases in NPL scores were observed in
chromosomes 2 (p = 0.0001), 18 (p = 0.00007), and 19 (p = 0.0003). Once we identified the linked
genomic region, we then attempted to identify the best plausible parametric model at that linked
locus. Our results show significant improvement in evidence for linkage and demonstrate that OSA
is a useful technique to detect linkage under heterogeneity.
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Rheumatoid arthritis (RA) is a chronic autoimmune
inflammatory disorder of unknown etiology. Although
environmental influences may trigger a response leading
to the development of this autoimmune disease, both
genetic and environmental factors are implicated in its
pathogenesis [1]. It affects approximately 1% of the adult
population with a female:male ratio ranging from 2:1 to
4:1 [2]. RA typically has an onset of symmetric joint swell-
ing and reaches a peak incidence in the fourth and fifth
decades of life [2]. RA-induced inflammatory response in
the synovial membrane is typically chronic and destruc-
tive [3]. The main presenting symptoms of RA are pain,
marked morning stiffness, impaired physical function,
swelling, and tenderness of the joints. Constitutional
symptoms of RA are fever, weight loss, and fatigue.
RA is a clinically heterogeneous disease and most likely
has complex genetic involvement. The presence of under-
lying genetic heterogeneity of a trait often masks the effect
of genetic markers with disease predisposing variants;
hence, there may not be linkage in families in which the
marker is not involved in the disease etiology [4]. One
method used to address genetic heterogeneity and
strengthen linkage findings is to incorporate phenotypic
subsetting of the data [5]. Most phenotypic stratification
approaches require that subsets be identified before link-
age studies. We have applied this technique to detect link-
age in another autoimmune disease, systemic lupus
erythematosus (SLE) [6]. Alternatively, one can account
for disease heterogeneity is by incorporating trait-related
covariate data. Therefore, to map genes for complex trait,
genetic analysis methods should acknowledge the pres-
ence of genetic heterogeneity when appropriate. In the
present analysis, we used ordered-subset analysis (OSA), a
powerful technique for linkage analysis of traits character-
ized by genetic heterogeneity [7]. In OSA, using different
covariates based on clinical features of the phenotype or
on environmental exposures, one can identify more
homogeneous subsets of families. Linkage that would
otherwise be missed may then be apparent. Therefore, the
goal of OSA is to identify regions with increased linkage in
a subset of families. Additionally, by increasing genetic
homogeneity, OSA can also reduce the linkage interval as
exemplified by other complex, diseases including Alzhe-
imer disease [8].
The aims of our present analysis are to: 1) identify homo-
geneous subset of families and assess linkage and its loca-
tion, 2) rigorously analyze the homogenous subsets of
families with statistically significant chromosomal loca-
tions to find a parsimonious genetic model.
Data and methods
We analyzed data from the North American Rheumatoid
Arthritis Consortium (NARAC) study as part of the
Genetic Analysis Workshop 15 (GAW15). Only Caucasian
families were used for these analyses. Initially, out of the
original 637 families, 31 families were removed due to
mixed ethnicity or because they were uninformative for
linkage analysis (single affected member per family). In
larger families, ungenotyped individuals were trimmed to
facilitate computation that otherwise was not possible
due to time and memory constraints on the computer
hardware used. We performed genome-wide linkage anal-
ysis of 809 Illumina SNP markers in 5713 individuals
from 606 Caucasian rheumatoid arthritis families. Analy-
ses were performed using FLOSS (Flexible Ordered Subset
Analysis), MERLIN, GeneHunter, GeneHunter-Modscore,
and Genehunter-Plus with the ASM (allele sharing model)
module. We used several complementary programs to
compare the accuracy of our results.
To date, several clinical and epidemiological factors have
been identified as potential trait-related covariates for RA.
Among them, increasing age of onset has been associated
with worse outcome in RA, with evidence that there has
recently been a shift towards an older age of onset [9].
There are also age differences in the strength of the associ-
ation with risk factors like HLA, which might suggest that
age has an effect on disease phenotype [10]. Recently,
anti-CCP antibodies have been identified as highly spe-
cific for RA. These antibodies have also demonstrated
prognostic utility with regard to radiographic outcomes
[11,12]. Therefore, we selected covariates 'age of onset'
and 'anti-CCP level' (anti-cyclic citrinullated peptide) and
used them in OSA to identify homogeneous subgroup of
families for linkage analysis. These covariates were used to
assign linkage scores to each family using MERLIN. Mean
covariate value for the family members was specified for
each family and the families were ordered according to
their covariate score. Multipoint linkage analysis was per-
formed on all subsets of families with k smallest or k larg-
est covariate scores. Thus, the subset type used here was
extreme. The FLOSS program was used to create a covari-
ate file for family covariate scores for all families and all
covariates, and to calculate nonparametric linkage (NPL)
scores. Permutation tests were used to assess the null
hypothesis of independence of family linkage scores at
each locus and family covariate scores. Each subset of
homogeneous families that generated a statistically signif-
icant linkage was analyzed with GeneHunter to further
confirm the NPL score.
Once we identified the linked genomic region, we then
attempted to identify the most plausible parametric
model (allele frequency, penetrance, and mode of inherit-
ance) at that linked location. For each subset, parametricPage 2 of 6
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score. These allele frequencies and penetrance values were
utilized in GeneHunter/GeneHunter-Plus with ASM mod-
ule, which provides NPL, nonparametric LOD, parametric
LOD, and heterogeneity LOD (HLOD) scores. In addi-
tion, information content was provided, which gave an
index of the inheritance information extracted at each
point in the genome by the marker genotyped. The LIN
function (linear model to evaluate the evidence for link-
age as defined by Kong and Cox [18]) of allele sharing
method was used to calculate nonparametric LOD scores.
Results
The results of OSA along with the other relevant statistics
are provided in Table 1. A significant increase in the evi-
dence of linkage was observed at five chromosomal
regions (Fig. 1). Using the covariate 'age of onset', statisti-
cally significant evidence of linkage was observed at chro-
mosomes 4 (NPL = 4.5, p = 0.000003, peak at 102.03 cM,
472 families) and suggestive evidence was observed at
chromosome 9 (NPL = 2.85, p = 0.002, peak at 0.59 cM,
27 families). With covariate 'anti-CCP level', statistically
significant evidence of linkage was identified at chromo-
some 18 (NPL = 3.81, p = 0.00007, peak at 26.29 cM, 40
families), and suggestive evidence of linkage was observed
at chromosome 2 (NPL = 3.66, p = 0.0001 peak at 154.11
cM, 219 families) and chromosome 19 (NPL = 3.28, p =
0.0003, peak at 52.21 cM, 10 families). The information
content extracted at the linked region ranged from 46% to
80%.
For each linkage region, the NPL score was significantly
increased (p < 0.05) when we used all families versus sub-
set of families. Further, the results with the GeneHunter
program using the ordered subset families produced a sta-
tistically significant linkage that confirms the nearly iden-
tical NPL score obtained by the FLOSS program. Table 2
shows the results for parametric and nonparametric LOD
scores obtained by incorporating the allele frequencies
and penetrance of the best fitted model into GeneHunter-
Plus with ASM module. Interestingly, these LOD scores
are very similar at each linkage peak.
With the covariate 'age of onset', the age range in the
ordered subset of families on chromosome 4 is between
31.5 and 83 years, whereas on chromosome 9 it is shifted
more toward old age (59.5 and 83 years). The optimal
range of 'anti-CCP level' in the ordered subset of families
was greater in chromosomes 2 (133 to 413) and 18 (234
to 413), but lower for chromosome 19 (0.800 to 3.50).
The values of peak maximized LOD (MOD) score and
HLOD scores are nearly equal (which is expected). After
using the allele-sharing model, not much difference was
seen between the peak MOD score and nonparametric
LOD scores produced by ASM except on chromosome 19.
Discussion
We have identified five linked chromosomal regions (2, 4,
9, 18, and 19) that may harbor the susceptibility genes for
RA. Previous studies [13,14] had identified linkage at
chromosomes 2, 4, and 18. Our results also support the
possibility of RA susceptibility gene in chromosomes 4
and 9 using the covariate 'age of onset' and in chromo-
somes 2, 18, and 19 using the covariate 'anti-CCP level'. It
is interesting to note that the optimal range changes very
little for 'anti-CCP level' on chromosome 2 and 18 link-
Table 1: Summary of ordered subset linkage analysis
Max No. families Covariate range
Covariates Chr. no. Linkage 
peak (cM)a













4 102.03 4.45 3.55 0.9 0.012 606 +472 [31.5–83.0] [11.0–83.0] 0.021 [0.0078, 0.0194]
9 0.59 2.85 1.18 1.67 0.022 606 +27 [59.5–83.0] [11.0–83.0] 0.022 [0.0141, 0.0349]
Anti-CCP 
level
2 154.17 3.72 2.83 0.9 0.048 590 +219 [133–413] [0.8–413] -0.951 [0.0302, 0.0742]
18 26.29 3.73 2.46 1.27 0.022 590 +40 [234–413] [0.8–413] 0.022 [0.0138, 0.0342]
19 52.22 3.27 1.01 2.26 0.009 590 -10 [0.8–3.50] [0.8–413] 0.009 [0.0057, 0.0142]
a Location of maximum score, maximized over all ordered subsets.
b Maximum score, maximized over all loci and ordered subsets.
c Maximum score using all families with a covariate value, maximized over all loci.
d Delta Max = (New Max) - (Old Max)
e Probability of observing a change in LOD score greater than or equal to delta max if family linkage scores and family covariate scores are 
independent.
f + or -, the best ordered subset consists of families with the highest (+) or lowest (-) covariate scores.
g Range of covariate values in the ordered subset with highest linkage score.
h Range of covariate scores in the set of all families.Page 3 of 6
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lutely no overlap. This would suggest an easily identifiable
subset of family. However, we have only 10 families in
this group, therefore, another independent replication is
required to assess the validity of this finding.
We considered both nonparametric and parametric link-
age analysis in this study. Both parametric and nonpara-
metric results are very similar in terms of detecting the
peak linkage locations. If we use the nonparametric LOD
score then we have evidence for three statistically signifi-
cant linkages at chromosomes 2, 4, and 18 that exceed the
Results of NPL analysis across the SNP marker positionsFig re 1
Results of NPL analysis across the SNP marker positions. Results of NPL analysis across the SNP marker positions in 
chromosomes (2, 4, 9, 18, and 19) showing the evidence of linkage in ordered subset of the families (solid line) based on cov-
ariate scores compared to all 606 families (dashed line) using GeneHunter.Page 4 of 6
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However, this threshold is not corrected for multiple test-
ing (at least four different tests were performed: two differ-
ent covariates and two different linkage methods,
nonparametric as well as parametric). To maintain the
overall genome-wide significance level (5% level), we
have used an ad hoc correction procedure that raised the
threshold of LOD score to 3.9. [This is calculated as:
LOD(corrected) = LOD(conv) + log10(#test) [16,17], where
LOD(conv) is conventional LOD score to be significant =
3.3.] Interestingly, all three linkages remain significant
after correcting for multiple testing.
For a complex trait like RA, successful identification of
genetic risk loci has relied on the ability to minimize dis-
ease and genetic heterogeneity to increase the power to
detect linkage. One way to account for disease heterogene-
ity is by incorporating covariate data. Phenotypically sim-
ilar families may be genetically more homogeneous as
well, in which case OSA can greatly improve the power of
linkage analysis. Our results clearly show that 'age at
onset' and 'anti-CCP level' are potentially two clinical
markers that can be useful to detect linkage for RA and
that OSA is an important technique to identify the linkage
in the presence of heterogeneity. Such linkage studies
could now be used for candidate gene as well as and fine
mapping studies to identify the actual RA susceptibility
genes.
Conclusion
A genome-wide OSA was performed to identify the link-
age for RA. We used two continuous covariates, 'age of
onset' and 'anti-CCP level' to identify a more homogene-
ous group. We have identified two statistically significant
regions with evidence of linkage at chromosomes 4 and
18 and three regions with suggestive evidence of linkage at
chromosomes 2, 9, and 19. Our results clearly demon-
strated that OSA is a useful technique to detect linkage
under heterogeneity.
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